These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 14619899)

  • 1. Low-molecular-weight heparin and thrombocytosis: a further reason to monitor the platelet count.
    Prescrire Int; 2003 Oct; 12(67):183. PubMed ID: 14619899
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thrombocytosis in patients treated with low-molecular-weight heparin: more common than imagined?].
    Wautrecht JC
    J Mal Vasc; 2011 Feb; 36(1):1-2. PubMed ID: 21146338
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thrombocytosis in patients treated with low-molecular-weight heparin: more common than imagined?].
    Lambert M; Trillot N; Cooren G; Glantenet R; Jude B; Hatron PY
    J Mal Vasc; 2010 Dec; 35(6):348-51. PubMed ID: 20888159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A benchmark for platelet count monitoring with low-molecular-weight heparin: expanding implementation of National Patient Safety Goals.
    Spinler SA
    Ann Pharmacother; 2009 Sep; 43(9):1519-21. PubMed ID: 19690223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT).
    Rota E; Bazzan M; Fantino G
    Thromb Haemost; 2008 Apr; 99(4):779-81. PubMed ID: 18392338
    [No Abstract]   [Full Text] [Related]  

  • 6. [Daily thrombocyte count in low molecular weight heparin treatment].
    Spannagl M
    Chirurg; 2008 Mar; Suppl():85. PubMed ID: 18711818
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thrombocytosis: adverse effect of heparin treatment].
    Camou F; Viallard JF; Caubet O; Pellegrin JL
    Presse Med; 2006 Jan; 35(1 Pt 1):58-60. PubMed ID: 16462666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-molecular-weight heparins and thrombocytosis.
    Liautard C; Nunes AM; Vial T; Chatillon F; Guy C; Ollagnier M; Descotes J
    Ann Pharmacother; 2002 Sep; 36(9):1351-4. PubMed ID: 12196050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-induced thrombocytopenia after liver transplantation.
    Kaneko J; Sugawara Y; Tamura S; Togashi J; Matsui Y; Makuuchi M
    Transplant Proc; 2008 Jun; 40(5):1518-21. PubMed ID: 18589141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heparin-induced thrombocytopenia in hemodialysis. Case report and review of the literature].
    Henríquez F; Rodríguez A; Mora C; Sánchez-Deig E; Macía M; Navarro J
    Nefrologia; 2006; 26(6):734-7. PubMed ID: 17227252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed-onset HIT caused by low-molecular-weight heparin manifesting during fondaparinux prophylaxis.
    Alsaleh KA; Al-Nasser SM; Bates SM; Patel A; Warkentin TE; Arnold DM
    Am J Hematol; 2008 Nov; 83(11):876-8. PubMed ID: 18803278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin, low molecular weight heparin, and heparin-induced thrombocytopenia in the ICU.
    Warkentin TE; Cook DJ
    Crit Care Clin; 2005 Jul; 21(3):513-29. PubMed ID: 15992671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thrombocytopenia induced by low molecular weight heparin].
    Ríos Herranz E; Briz Blanco M; Cabrera Marín JR; Fernández Rodríquez MN
    Med Clin (Barc); 1991 Apr; 96(16):635-6. PubMed ID: 1646919
    [No Abstract]   [Full Text] [Related]  

  • 14. Compliance with platelet count monitoring recommendations and management of possible heparin-induced thrombocytopenia in hospitalized patients receiving low-molecular-weight heparin.
    ten Berg MJ; van den Bemt PM; Huisman A; Schobben AF; Egberts TC; van Solinge WW
    Ann Pharmacother; 2009 Sep; 43(9):1405-12. PubMed ID: 19690229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparins, low-molecular-weight heparins, and pentasaccharides.
    Dinwoodey DL; Ansell JE
    Clin Geriatr Med; 2006 Feb; 22(1):1-15, vii. PubMed ID: 16377464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of anti-PF4/heparin antibodies and the HIT syndrome in cardiovascular medicine.
    Mattioli AV
    Semin Thromb Hemost; 2004 Jun; 30(3):291-5. PubMed ID: 15282651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timely diagnosis and management of heparin-induced thrombocytopenia in a frequent request, low incidence single centre using clinical 4T's score and particle gel immunoassay.
    Bryant A; Low J; Austin S; Joseph JE
    Br J Haematol; 2008 Dec; 143(5):721-6. PubMed ID: 19036016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thrombopenia caused by low molecular weight heparin].
    Tardy B; Page Y; Tardy-Poncet B; Comtet C; Zeni F; Bertrand JC
    Therapie; 1990; 45(5):453. PubMed ID: 2175456
    [No Abstract]   [Full Text] [Related]  

  • 19. [Thrombopenia induced by a low molecular weight heparin].
    Wattrisse G; Lecoutre D; Groux-Pante C
    Cah Anesthesiol; 1990; 38(3):175-7. PubMed ID: 2169975
    [No Abstract]   [Full Text] [Related]  

  • 20. Utility of consecutive repeat HIT ELISA testing for heparin-induced thrombocytopenia.
    Chan M; Malynn E; Shaz B; Uhl L
    Am J Hematol; 2008 Mar; 83(3):212-7. PubMed ID: 17910041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.